Literature DB >> 23376089

Dynamic change and impact of myeloid-derived suppressor cells in allogeneic bone marrow transplantation in mice.

Dapeng Wang1, Yu Yu, Kelley Haarberg, Jianing Fu, Kane Kaosaard, Srinivas Nagaraj, Claudio Anasetti, Dmitry Gabrilovich, Xue-Zhong Yu.   

Abstract

Myeloid-derived suppressor cells (MDSCs) are a group of myeloid cells composed of hematopoietic progenitor cells, immature macrophages, dendritic cells, and granulocytes, which accumulate in inflammatory diseases and various cancers. Here, we investigated the dynamic changes and effects of MDSCs in graft-versus-host disease (GVHD) development and/or tumor relapse after syngeneic and allogeneic bone marrow transplantation (BMT). We found that adding functional MDSCs in donor graft alleviated GVHD, whereas removal of MDSCs in vivo exacerbated GVHD. After T cell-deplete BMT, MDSCs transiently accumulated in the blood and spleen of recipients without GVHD. In contrast, after T cell-replete BMT, the levels of blood MDSCs were constantly elevated in recipients with GVHD. MDSC accumulation positively correlated with the severity of GVHD. Additionally, MDSC accumulation was further increased upon tumor relapse. Although MDSCs isolated from both syngeneic and allogeneic BMT recipients inhibited T cell proliferation in response to alloantigen stimulation ex vivo, MDSCs from the recipients with GVHD showed much higher suppressive potency compared with those from recipients without GVHD. These results indicate that MDSCs can regulate the immune response in acute GVHD, and possibly tumor relapse, subsequent to allogeneic BMT.
Copyright © 2013 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23376089      PMCID: PMC4011929          DOI: 10.1016/j.bbmt.2013.01.008

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  41 in total

1.  Graft-vs.-host and graft-vs.-leukemia reactions after delayed infusions of donor T-subsets.

Authors:  B D Johnson; E E Becker; R L Truitt
Journal:  Biol Blood Marrow Transplant       Date:  1999       Impact factor: 5.742

Review 2.  Murine graft-versus-host disease across minor barriers: immunosuppressive aspects of natural suppressor cells.

Authors:  J H Holda; T Maier; H N Claman
Journal:  Immunol Rev       Date:  1985-12       Impact factor: 12.988

3.  Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines.

Authors:  G R Hill; J M Crawford; K R Cooke; Y S Brinson; L Pan; J L Ferrara
Journal:  Blood       Date:  1997-10-15       Impact factor: 22.113

4.  An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin.

Authors:  K R Cooke; L Kobzik; T R Martin; J Brewer; J Delmonte; J M Crawford; J L Ferrara
Journal:  Blood       Date:  1996-10-15       Impact factor: 22.113

5.  Association of increased immunostaining for inducible nitric oxide synthase and nitrotyrosine with fibroblast growth factor transformation in pancreatic cancer.

Authors:  S M Vickers; L A MacMillan-Crow; M Green; C Ellis; J A Thompson
Journal:  Arch Surg       Date:  1999-03

Review 6.  Regulation of immune responses by L-arginine metabolism.

Authors:  Vincenzo Bronte; Paola Zanovello
Journal:  Nat Rev Immunol       Date:  2005-08       Impact factor: 53.106

7.  Prevention of graft versus host disease by inactivation of host antigen-presenting cells.

Authors:  W D Shlomchik; M S Couzens; C B Tang; J McNiff; M E Robert; J Liu; M J Shlomchik; S G Emerson
Journal:  Science       Date:  1999-07-16       Impact factor: 47.728

8.  Synergy between T-cell immunity and inhibition of paracrine stimulation causes tumor rejection.

Authors:  L P Seung; D A Rowley; P Dubey; H Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-03       Impact factor: 11.205

9.  Mechanisms of immune suppression in patients with head and neck cancer: presence of CD34(+) cells which suppress immune functions within cancers that secrete granulocyte-macrophage colony-stimulating factor.

Authors:  A S Pak; M A Wright; J P Matthews; S L Collins; G J Petruzzelli; M R Young
Journal:  Clin Cancer Res       Date:  1995-01       Impact factor: 12.531

10.  Hematopoiesis and suppressor bone marrow cells in mice bearing large metastatic Lewis lung carcinoma tumors.

Authors:  M R Young; M Newby; H T Wepsic
Journal:  Cancer Res       Date:  1987-01-01       Impact factor: 12.701

View more
  33 in total

1.  Amplification of functional myeloid-derived suppressor cells during stem cell mobilization induced by granulocyte colony-stimulation-factor.

Authors:  Xiao-Jian Zhu; Jing Hu; Li Sun; Yin Xiao; Zhi-Chao Chen; Yong You; Ping Zou; Hong-Xiang Wang; Zhao-Dong Zhong
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-12-13

Review 2.  Role of myeloid-derived suppressor cells in allogeneic hematopoietic cell transplantation.

Authors:  Brent H Koehn; Bruce R Blazar
Journal:  J Leukoc Biol       Date:  2017-02-01       Impact factor: 4.962

Review 3.  Haploidentical SCT: the mechanisms underlying the crossing of HLA barriers.

Authors:  Y-J Chang; X-J Huang
Journal:  Bone Marrow Transplant       Date:  2014-02-24       Impact factor: 5.483

4.  Radiation and host retinoic acid signaling promote the induction of gut-homing donor T cells after allogeneic hematopoietic stem cell transplantation.

Authors:  Jianwei Zheng; Brian Taylor; Joseph Dodge; Allison Stephans; Song Guo Zheng; Qiang Chen; Xiao Chen
Journal:  Am J Transplant       Date:  2019-07-15       Impact factor: 8.086

Review 5.  Reciprocal relationship between myeloid-derived suppressor cells and T cells.

Authors:  Srinivas Nagaraj; Je-In Youn; Dmitry I Gabrilovich
Journal:  J Immunol       Date:  2013-07-01       Impact factor: 5.422

6.  Bendamustine with Total Body Irradiation Limits Murine Graft-versus-Host Disease in Part Through Effects on Myeloid-Derived Suppressor Cells.

Authors:  Jessica Stokes; Emely A Hoffman; Megan S Molina; Jelena Eremija; Nicolas Larmonier; Yi Zeng; Emmanuel Katsanis
Journal:  Biol Blood Marrow Transplant       Date:  2018-10-13       Impact factor: 5.742

7.  The impact of circulating suppressor cells in multiple myeloma patients on clinical outcome of DLIs.

Authors:  L E Franssen; N W C J van de Donk; M E Emmelot; M W H Roeven; N Schaap; H Dolstra; W Hobo; H M Lokhorst; T Mutis
Journal:  Bone Marrow Transplant       Date:  2015-03-23       Impact factor: 5.483

8.  Bidirectional immune tolerance in nonmyeloablative MHC-mismatched BMT for murine β-thalassemia.

Authors:  Shuyu E; Aman Seth; Peter Vogel; Matt Sommers; Taren Ong; Asha B Pillai
Journal:  Blood       Date:  2017-03-28       Impact factor: 22.113

Review 9.  Immune regulatory cell infusion for graft-versus-host disease prevention and therapy.

Authors:  Bruce R Blazar; Kelli P A MacDonald; Geoffrey R Hill
Journal:  Blood       Date:  2018-05-04       Impact factor: 22.113

10.  GVHD-associated, inflammasome-mediated loss of function in adoptively transferred myeloid-derived suppressor cells.

Authors:  Brent H Koehn; Petya Apostolova; Jessica M Haverkamp; Jeffrey S Miller; Valarie McCullar; Jakub Tolar; David H Munn; William J Murphy; Willie June Brickey; Jonathan S Serody; Dmitry I Gabrilovich; Vincenzo Bronte; Peter J Murray; Jenny P-Y Ting; Robert Zeiser; Bruce R Blazar
Journal:  Blood       Date:  2015-08-11       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.